• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW ORTHOPAEDICS LTD BHR MODULAR HEAD 40MM; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW ORTHOPAEDICS LTD BHR MODULAR HEAD 40MM; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING Back to Search Results
Catalog Number 74222140
Device Problems Biocompatibility (2886); Adverse Event Without Identified Device or Use Problem (2993); Appropriate Term/Code Not Available (3191)
Patient Problems Pain (1994); Toxicity (2333); Arthralgia (2355); Metal Related Pathology (4530)
Event Date 04/25/2018
Event Type  Injury  
Event Description
Can legal mdl it was reported that a revision surgery was performed on the patients left hip due to pain and high metal ion levels.The patient outcome is unknown.
 
Manufacturer Narrative
It was reported that left hip revision surgery was performed.During the revision, the modular head, r3 liner and modular sleeve were removed.The r3 shell and stem remained implanted.As of today, the implanted devices, all of which were used in treatment, and additional information have been requested for this complaint but have not become available.A review of the complaint history for the r3 liner and modular head was performed using batch numbers in search of similar recurring reports for the products during their lifetimes.No other similar complaints were identified for the r3 liner.Similar complaints have been identified for the modular head.However, as the device is no longer sold, no action is to be taken.In the absence of the actual devices, the production records were reviewed for the devices reportedly involved in this incident.All the released devices involved met manufacturing specifications at the time of production.Review of the product ifu found adequate warnings and precautions in relation to the alleged failure modes.A risk management review was performed.No additional risks were identified as result of the reported event.The available medical documents were reviewed.Although it was reported that the patient had elevated metal ion levels, neither the levels nor the lab reports were provided for review.Without the supporting lab/pathology results, imaging, and/or the analysis of the explanted components, the root cause of the reported pain, elevated metal ion levels and trunnionosis cannot be confirmed and it cannot be concluded that the reported clinical reactions were associated with a mal-performance of the implant.The patient impact beyond the pain, revision, and expected transient post-op convalescence period cannot be determined.Without return of the actual devices or further information we cannot further investigate or confirm the details supplied in this complaint, and our investigation remains inconclusive.If the products or additional information become available in the future, this case will be reopened.No preventative or corrective action has been initiated as a result of this investigation.
 
Manufacturer Narrative
H3, h6: it was reported that a left revision surgery was performed due to pain and high metal ion levels.The r3 metal liner, modular head and sleeve were explanted.As of today, the implanted devices, all of which were used in treatment have not been returned for evaluation.A review of the historical complaints data for the modular head and sleeve was performed using batch numbers, part numbers and the reported failure modes to evaluate patterns of repeated failures or defects.Similar complaints have been identified for the modular head and sleeve.However, as the devices are no longer sold, no action is to be taken.In the absence of the actual devices, the production records were reviewed for the devices reportedly involved in this incident.All released devices involved met manufacturing specifications upon release for distribution.Review of the product ifu found adequate warnings and precautions in relation to the alleged failure modes.A risk management review was performed.The alleged failure modes and associated risks have been anticipated within the risk file and the anticipated risk level is still adequate.No further actions are required at this time.A review of historic escalation actions related to the products and similar complaint events was performed.Following the review, prior applicable escalation actions were identified and confirmed to reduce associated risks as far as possible.No further escalation actions required.The available medical documents were reviewed.Without the supporting lab/pathology reports, imaging, and/or the analysis of the explanted components, the root cause of the reported pain, elevated cobalt levels and trunnionosis cannot be confirmed and it cannot be concluded that the reported clinical reactions were associated with a mal-performance of the implant.The patient impact beyond the pain, revision, and expected transient post-op convalescence period cannot be determined.Based on the available information we can confirm the reported complaint, however without further information our investigation remains inconclusive, and a definitive root cause cannot be determined.Specific factors known to contribute to the alleged fault are excessive physical activity levels, unreasonable stress on replacement system, excessive patient weight, trauma to the joint replacement, loosening of components may increase production of wear particles and accelerate damage to the bone.Should the devices or additional information be received, the complaint will be reopened.Based on this investigation, the need for corrective and preventative actions is not indicated.
 
Event Description
It was reported that, after an r3-tha construct had been implanted on (b)(6) 2011, the patient experienced pain and pain and had high metal ion levels.A revision surgery was performed on (b)(6) 2018: liner, head and sleeve were explanted, while the acetabular cup and the stem were left in-situ.
 
Manufacturer Narrative
Additional information in: a2, a3, b5, b6, e1 and h6 (updated medical device problem code).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BHR MODULAR HEAD 40MM
Type of Device
PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING
Manufacturer (Section D)
SMITH & NEPHEW ORTHOPAEDICS LTD
aurora house, spa park
leamington spa warwickshire CV31 3HL
UK  CV31 3HL
Manufacturer (Section G)
SMITH & NEPHEW ORTHOPAEDICS LTD
aurora house, spa park
leamington spa warwickshire CV31 3HL
UK   CV31 3HL
Manufacturer Contact
sarah freestone
aurora house, spa park
leamington spa warwickshire CV31 -3HL
UK   CV31 3HL
0447940038
MDR Report Key10173308
MDR Text Key195713985
Report Number3005975929-2020-00199
Device Sequence Number1
Product Code NXT
UDI-Device Identifier03596010552457
UDI-Public3596010552457
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
P040033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Consumer,Health Professional,User Facility,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup,Followup,Followup
Report Date 10/28/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/19/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/30/2013
Device Catalogue Number74222140
Device Lot Number08HW18354
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received10/24/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/31/2008
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
MODULAR SLEEVE {} PLUS 0MM 12/14; SYN POR HO FEM COM SZ 12; MODULAR SLEEVE {} PLUS 0MM 12/14; SYN POR HO FEM COM SZ 12
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age67 YR
Patient SexMale
-
-